נובומיקס 30 פלקספן
novo nordisk ltd., israel - insulin aspart - תרחיף להזרקה - insulin aspart 100 u/ml - insulin aspart - insulin aspart - treatment of diabetes mellitus.
ויקטוזה
novo nordisk ltd., israel - liraglutide - תמיסה להזרקה - liraglutide 6.0 mg/ml - liraglutide - liraglutide - for the treatment of adults with type 2 diabetes mellitus to achieve glycemic control : in combination with : - metformin or a sulphonylurea, in patients with insufficient glycemic control despite maximal tolerated dose of monotherapy with mentformin or sulphonylurea. - metformin and sulphonylurea or metformin and a thiazolidinedione in patients with insufficient glycemic control despite dual therapy.
נורדיטרופין 15 מג
novo nordisk ltd., israel - somatropin - תמיסה להזרקה - somatropin 10 mg / 1 ml - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (current height sds < - 2.5 and parental adjusted height sds < - 1) in short children born small for gestational age (sga) with a birth weight and/or length below - 2 sd who failed to show catch-up growth (hv sds < during the last year) by 4 years of age or later.children with short stature associated with noonan syndrome.adults: treatment of adults with hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of g.h. deficiency.
נורדיטרופין 10 מג
novo nordisk ltd., israel - somatropin - תמיסה להזרקה - somatropin 10 mg / 1.5 ml - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (current height sds < - 2.5 and parental adjusted height sds < - 1) in short children born small for gestational age (sga) with a birth weight and/or length below - 2 sd who failed to show catch-up growth (hv sds < during the last year) by 4 years of age or later.children with short stature associated with noonan syndrome.adults: treatment of adults with hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of g.h. deficiency.
נורדיטרופין 5 מג
novo nordisk ltd., israel - somatropin - תמיסה להזרקה - somatropin 3.3 mg / 1 ml - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (current height sds < - 2.5 and parental adjusted height sds < - 1) in short children born small for gestational age (sga) with a birth weight and/or length below - 2 sd who failed to show catch-up growth (hv sds < during the last year) by 4 years of age or later.children with short stature associated with noonan syndrome.adults: treatment of adults with hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of g.h. deficiency.
גלוקגן היפוקיט 1 מג
novo nordisk ltd., israel - glucagon as hydrochloride - אבקה וממס להכנת תמיסה להזרקה - glucagon as hydrochloride 1 mg - glucagon - glucagon - treatment of severe hypoglycaemia reactions which may occur in the management of insulin treated persons with diabetes.
זולטופיי
novo nordisk ltd., israel - insulin degludec; liraglutide - תמיסה להזרקה - insulin degludec 100 u/ml; liraglutide 3.6 mg/ml - insulin degludec and liraglutide
טרגלודק 100 יחידותמיליליטר
novo nordisk ltd., israel - insulin degludec - תמיסה להזרקה - insulin degludec 100 u/ml - insulin degludec
לבמיר
novo nordisk ltd., israel - insulin detemir - תמיסה להזרקה - insulin detemir 100 u/ml - insulin detemir
נובוטרטין
novo nordisk ltd., israel - factor xiii - אבקה וממס להכנת תמיסה להזרקה - factor xiii 2500 iu / 3 ml - coagulation factor xiii